A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.

NCT02547974 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Disorders

Interventions

BIOLOGICAL: Formulation 1 (plain): NTHi/Mcat vaccine GSK3277513A
BIOLOGICAL: Formulation 2 (adjuvanted): NTHi/Mcat vaccine GSK3277513A
BIOLOGICAL: Formulation 3 (adjuvanted): NTHi/Mcat vaccine GSK3339036A
DRUG: Placebo

Sponsor

GlaxoSmithKline